2012-11-01
Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response
Publication
Publication
Inflammatory Bowel Diseases , Volume 18 - Issue 11 p. 2026- 2033
Additional Metadata | |
---|---|
, , | |
doi.org/10.1002/ibd.22902, hdl.handle.net/1765/89285 | |
Inflammatory Bowel Diseases | |
Organisation | Erasmus MC: University Medical Center Rotterdam |
Katz, L, Gisbert, J.P, Manoogian, B, Lin, K, Steenholdt, C, Mantzaris, G.J, … Ben-Horin, S. (2012). Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response. Inflammatory Bowel Diseases, 18(11), 2026–2033. doi:10.1002/ibd.22902
|